Accordingly, it is proposed that NAC may inhibit bleomycin-induced development of pulmonary fibrosis by increasing the MMP-9/TIMP-1 and MMP-9/TIMP-3 ratios, which eventually increases the degradation of collagen in the lungs to prevent its excessive deposition in the form of fibrosis. Here, TIMP1 is linked to pulmonary fibrosis.